Submit Deal

VERACYTE

Summary

Veracyte is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis.

Deals Overview

Total Deals3

Valued Deals3

Total Value£ 738 M

Avg. Deal Size£ 246 M

Market Context

Senior Management

Bonnie Anderson
Chairman and CEO
Marc Stapley
CEO
Keith Kennedy
CFO

Sort

fenwick & west

HQ - Silicon Valley

legal advisors (3)

3 Shared Deals

3 For

£ 738 M

Total Value

goldman sachs

HQ - New York, United States

financial advisors (2)

2 Shared Deals

2 For

£ 664 M

Total Value

freshfields

HQ - London

legal advisors (1)

1 Shared Deal

1 For

£ 439 M

Total Value

evercore

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 439 M

Total Value

cooley

HQ - Palo Alto

legal advisors (1)

1 Shared Deal

1 Opposite

£ 439 M

Total Value

shearman & sterling

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

£ 224 M

Total Value

atcg partners

pr advisors (1)

1 Shared Deal

1 Opposite

£ 224 M

Total Value

latham & watkins

HQ - New York, United States

legal advisors (2)

2 Shared Deals

2 For

£ 299 M

Total Value

joele frank

HQ - New York, United States

pr advisors (1)

1 Shared Deal

1 For

£ 224 M

Total Value

jones day

HQ - Cleveland

legal advisors (1)

1 Shared Deal

1 Opposite

£ 224 M

Total Value

perella weinberg partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 75 M

Total Value

meitar law offices

HQ - Ramat Gan, Israel

legal advisors (1)

1 Shared Deal

1 Opposite

£ 75 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy